**Core Concept**
Ophthalmic enucleation, also known as eye removal, is a surgical procedure where the eyeball is removed. This can be performed due to various reasons, including severe trauma, malignant tumors, or severe ocular conditions. In the context of ophthalmic enucleation, the indication is critical, and it is essential to identify the absolute indications for this procedure.

**Why the Correct Answer is Right**
The correct answer is retinoblastoma, a malignant tumor of the retina that primarily affects children but can also occur in adults. In cases of retinoblastoma, ophthalmic enucleation is often the only viable treatment option to prevent the spread of the tumor to other parts of the body. The tumor's location in the retina and its potential to invade surrounding tissues make enucleation the most effective treatment. Additionally, retinoblastoma can cause vision loss, pain, and even death if left untreated.

**Why Each Wrong Option is Incorrect**
**Option A:** Retinal detachment is a condition where the retina separates from the underlying tissue. While it is a serious condition, it is not an absolute indication for ophthalmic enucleation. Treatment options for retinal detachment include retinal reattachment surgery, laser photocoagulation, or vitrectomy.
**Option B:** Endophthalmitis is a severe inflammation of the interior of the eye, usually caused by an infection. It is a medical emergency, but treatment usually involves antibiotics and drainage of the abscess, not enucleation.
**Option C:** Malignant melanoma is a type of cancer that affects the eye, but it is not typically an indication for enucleation. Treatment options for malignant melanoma include brachytherapy, cryotherapy, or enucleation in advanced cases.

**Clinical Pearl / High-Yield Fact**
It is essential for clinicians to recognize the signs and symptoms of retinoblastoma, which include leukocoria (white reflex), strabismus, and vision loss. Early diagnosis and treatment are critical for preventing the spread of the tumor and improving patient outcomes.

**Correct Answer: D. Retinoblastoma.**